Related Articles
Toremifene-induced fatty liver and NASH in breast cancer patients with breast-conservation treatment.
Primary toremifene treatment for elderly postmenopausal women with breast cancer
Breast-conservation treatment for bilateral breast cancer in five Japanese women
Breast-conservation treatment for patients with ductal carcinoma in situ.
Synergistic antitumour effect of a combination of toremifene and interferon-α on ZR-75-1 human breast cancer cells: Dependence on interferon-α subtype